FAQ’s

Within a week of when your sample is received at the lab, you can expect to receive both an email and a notification in your customer portal with your test results. Depending on your results, you may have the opportunity to schedule a consultation with a neurologist.

Your lab results and cognitive assessment results will be shared at the same time, which will be within a week of when the lab receives your sample.

You will receive an email, as well as a notification via your customer portal.

A neurologist will review both your blood test and cognitive assessment. Every neurologist we work with is board-certified and trained and certified by Neurogen to meet the highest standards of expertise in memory care.

If Alzheimer’s disease is detected, we’ll reach out to you to make a telehealth appointment with a neurologist, who will review your results and advise on next steps.

You can share your test results with whomever you choose. We will not share your test results with anyone else, including insurance providers, employers, or family members. Your privacy is of the utmost importance to us.

Our At-Home Test Kit includes a blood test that identifies the presence of a protein called P-tau217, which is a blood biomarker for Alzheimer’s. P-tau217 starts to build up years before symptoms appear, and testing for this protein allows for disease detection in the early stages.

Specialized brain scans, called positron emission tomography (PET) scans, can detect the buildup of plaques and tangles in the brain, which is an indicator of Alzheimer’s disease. PET scans, however, are not widely available and are not typically covered by insurance. Another test for detecting Alzheimer's is by measuring the brain fluid obtained by a lumbar puncture. This method is perceived as invasive and requires specialist medical personnel.

For many people, by the time they get tested for Alzheimer’s at a hospital, it’s too late to make any real changes that could slow down the disease progression.1

The founders of Neurogen Biomarking, who are doctors and scientists themselves, are committed to making the early detection of Alzheimer’s more accessible and affordable for everyone. With the recent breakthroughs in blood biomarker technology, our At-Home Test Kit provides information that is as accurate as traditional testing methods, but available at a fraction of the cost.

In recent years, advancements such as the ptau217 blood test have demonstrated high accuracy in detecting biological changes associated with Alzheimer's disease.

Dementia is a term for a range of symptoms affecting cognitive abilities, such as memory, language, and behavior. Alzheimer’s is the most common type of dementia, accounting for 60-80% of all diagnoses.²

Alzheimer’s disease is the buildup of protein plaques and tangles in your brain, which happens years before symptoms appear. These plaques and tangles affect the health of brain cells called neurons and causes them to stop functioning, lose connections with other neurons, and die. The death of these brain cells leads to the symptoms of Alzheimer's, including memory impairment, personality changes, and problems carrying out daily activities.³

There are many different symptoms of Alzheimer’s, which can range from changes in behavior to worsening memory or increased confusion. Some examples include challenges in solving problems, difficulty completing familiar tasks, confusion with time or place, withdrawal from work or social activities, and changes in mood and personality.⁴

Detecting Alzheimer’s early allows for timely treatment and lifestyle adjustments, which can help slow disease progression and protect quality of life. Alzheimer’s disease is the buildup of protein plaques and tangles in your brain, which happens years before symptoms appear. Early detection of these plaques and tangles can allow you to take actions that can significantly slow the progression of this disease and save you years of memory loss.¹

For more detailed information, visit our Benefits of Testing page.

You -- and only you -- will receive the results of your blood test and cognitive assessment. Neurogen will never share your information with insurance providers, employers, family members, or anyone else.

Neurogen will never share your information with insurance providers. If you choose to share your test results with your insurance provider, however, it is possible that your coverage may be affected.